Chronic use of diazepam in primary healthcare centers: User profile and usage pattern

Sao Paulo Medical Journal

Volumn 125, Issue 5, 2007, Pages 270-274

  Ribeiro, Carmen Sylvia ^a   Azevedo, Renata Cruz Soares ^a   da Silva, Viviane Franco ^a   Botega, Neury José ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anti anxiety agents; Benzodiazepines; Diazepam; Drug prescriptions; Primary health care

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM;

ADULT; AGITATION; ARTICLE; BEDTIME DOSAGE; BRAZIL; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; DEPRESSION; DESCRIPTIVE RESEARCH; DRUG ABUSE PATTERN; DRUG DEPENDENCE; DRUG INDICATION; DRUG OVERDOSE; FEMALE; HEADACHE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; IRRITABILITY; LIMB PAIN; MALE; MENTAL DISEASE; PHARMACOEPIDEMIOLOGY; PRIMARY HEALTH CARE; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL CLASS; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 38049134764     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802007000500004     Document Type: Article

References (34)

1. Denis C, Fatséas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev. 2006;3:CD005194.
2. Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 2005;17(3):189-97.
3. Fritsch Montero R, Rojas Castillo G, Gaete Olivares J, Araya Baltra R, Gonzaléz Rubio I. Benzodiazepine use in Santiago, Chile. Actas Esp Psiquiatr. 2005;33(5):286-91.
4. Ciuna A, Andretra M, Corbari L, et al. Are we going to increase the use of antidepressants up to that of benzodiazepines? Eur J Clin Pharmacol. 2004;60(9):629-34.
5. Vedia Urgell C, Bonet Monne S, Forcada Vega C, Parellada Esquius N. Estudio de utilización de psicofármacos en atención primaria. [Study of use of psychiatric drugs in primary care]. Aten Primaria. 2005;36(5):239-45.
6. Mari JJ, Almeida-Filho N, Coutinho E, Andreoli SB, Miranda CT, Streiner D. The epidemiology of psychotropic in the city of São Paulo. Psychol Med. 1993;23(2):467-74.
7. Wortmann AC, Grüdtner MC, Fialho AF, et al. O consumo de benzodiazepina em Porto Alegre. [Benzodiazipine consumption in Porto Alegre]. Rev Ass Med Bras. 1994;40(4):265-70.
8. Galduróz JC, Noto AR, Nappo SA, Carlini EA. Household survey on drug abuse in Brazil: study involving the 107 major cities of the country - 2001. Addict Behav. 2005;30(3):545-56.
9. o graus de 10 capitais brasileiras. São Paulo: Centro Brasileiro de Informações sobre Drogas Psicotrópicas (CEBRID); 1997.
10. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66(Suppl 2):9-13.
11. Laranjeira R, Castro LA. Potencial de abuso de benzodiazepínicos. In: Bernik MA, editor. Benzodiazepínicos: quatro décadas de experiência. São Paulo: Edusp; 1999. p. 187-98.
12. Voyer P, Cappeliez, P, Pérodeau C, Préville M. Mental health for older adults and benzodiazepine use. J Community Health Nurs. 2005;22(4):213-29.
13. Barker MJ, Greenwood KM, Jackson M, Crowe SF. An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use. J Int Neuropsychol Soc. 2005;11(3):281-9.
14. Barlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R. Longitudinal patterns of new Benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf. 2004;13(10):669-82.
15. Rosenbaum JF. Attitudes toward benzodiazepines over the years. J Clin Psychiatry. 2005;66(Suppl 2):4-8.
16. Mol AJ, Gorgels WJ, Oude Voshaar RC, et al. Associations of benzodiazepine craving with other clinical variables in a population of general practice patients. Compr Psychiatry. 2005;46(5):353-60.
17. O'brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66(Suppl 2):28-33.
18. Tamblyn R, Abrahamowicz M, du Berger R, McLeod P, Bartlett G. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc. 2005;53(2):233-41.
19. Bélanger L, Morin CM, Bastien C, Ladouceur R. Self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia, Health Psychol. 2005;24(3):281-7.
20. Howard M, Dolovich L, Kaczorowski J, Sellors C, Sellors J. prescribing of potentially inappropriate medications to elderly people. Fam Pract. 2004;21(3):244-7.
21. Almeida PM, Wickerhauser H. O critério ABA/ABIPEME: em busca de uma atualização. São Paulo: Associação Brasileira de Anunciantes (ABA)/Associação Brasileira dos Institutos de Pesquisa de Mercado (ABIPEME); 1991.
22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
23. Botega NJ, Bio MR, Zomignani MA, Garcia C, Pereira WA. Transtoranos do humor em enfermaria de clínica média e validação de escala de medida (HAD) de ansiodade e depressão. [Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD]. Rev Saúde Pública 1995;29(5):355-63.
24. WHO. Schedule for Clinical Assessment in Neuropsychiatry, Version 2.0. New York: US Department of Health and Human Services. Public Health Service Centers for Disease Control; 1998.
25. Mendonça RT, Carvalho ACD. O papel de mulheres idosas consumidoras de calmantes alopáticos na popularização do uso destes medicamentos. [The role of elderly female consumers of allopathic tranquilizers in the popularization of the use of these medicines], Rev Latinoam Enfermagem. 2005;13(2, n. esp):1207-12.
26. Horta BL, de Lima MS, Faleiros JJ, Weidepass E, Horta RL. Benzodiazepínicos: estudo de presrição em um posto de atenção primária à saúde. [Benzodiazepinics: prescription study in a primary health care unit] Rev Assoc Med Bras. 1994;40(4):262-4.
27. van Rijswijk E, Zandstra SM, van de Lisdonk EH, Zitman FG, van Weel C. Appropriateness of benzodiazepine prescribing in general practice. Int J Clin Pharmacol Ther. 2005;43(8):411-2.
28. Haydon E, Rehm J, Fisher B, Monga N, Adlaf E. Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Can J Public Health. 2005;96(6):459-61.
29. Voyer P, McCubbin M, Cohen D, Lauzon S, Collin J, Boivin C. Unconventional indicators of drug dependence among elderly long-term users of benzodiazepines. Issues Ment Health Nurs. 2004;25(6):603-28.
30. Stevens JC, Pollack MH. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry. 2005;66(Suppl 2):21-7.
31. Morgan JD, Wright DJ, Chrystyn H. Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines. Pharm World Sci. 2002;24(6):231-5.
32. Gask L, Dixon C, May C, Dowrick C. Qualitative study of an educational intervention for GPs in the assessment and management of depression. Br J Gen Pract. 2005;55(520):854-9.
33. Kan CC, Hilberink SR, Breteler MH. Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach. Compr Psychiatry. 2004;45(2):89-94.
34. Auchewski L, Andreatini R, Galduróz JC, de Lacerda RB. Avaliação. da orientação médica sobre os efeitos colaterais de benzodiazepínicos. [Evaluation of the medical orientation for the benzodiazepine side effects]. Rev Bras Psiquiatr. 2004;26(1):24-31.